News and Publications
-
amedes and ARCHIMEDlife – a new strong international alliance
ARCHIMEDlife News January 17, 2020ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and medical-diagnostic services for patients, physicians and… Read more -
SSIEM 2019 in Rotterdam
ARCHIMEDlife News August 27, 2019Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time presenting at SSIEM, 3 – 6… Read more -
New cut-offs for lysosomal enzyme activities.
ARCHIMEDlife News June 6, 2019We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal enzyme activities from Dried Blood Spots… Read more -
Improving our ability to diagnose Hemoglobinopathies.
ARCHIMEDlife News October 1, 2018Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University Medical Center Hamburg in Eppendorf Germany,… Read more
-
First LEA assay launched
ARCHIMEDlife News March 14, 2018LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses (MPS) can be diagnosed from one… Read more -
Awarded work: Hemoglobinopathies and Thalassemias
Our awarded work (Poster Finalist at MSACL Europe, also see the PDF Poster Hemoglobinopathies_MSACL) on hemoglobinopathies and thalassemias is now starting into a prospective study in… Read more